Search results
You searched for:
Found 1,536 results
Sorting options:
Date: 01/01/2026 Location: Other
This webinar is the third in a four-part series on ESUS and the importance of patent foramen ovale in ESUS aetiology and management.This activity aims to: • Outline the medical and surgical treatment options in PFO ESUS and how they are selected • Describe the procedures used in device-based therapy treatment of PFO and their supporting evidence • Demonstrate what a PFO occluder is • Outline an approach to a PFO that hasn’t caused a stroke • Explain the post-PFO occlusion recovery
1 Educational activity hour
Date: 01/01/2026 Location: Other
This webinar is the fourth in a four-part series on ESUS and the importance of patent foramen ovale in ESUS aetiology and management. This activity will use an interactive panel conversation to explore the following via a case study: · How does ESUS shift the thinking for post stroke discharge back to general practice o Do all my stroke patients have a cause for stroke outlined in the discharge summary? o What is the role of the GP in ensuring a stroke work up is completed? o What about our rural and remote patients? · Lifestyle/post-procedural management o MRI safety o Medication management o AF risk o Do PFOs need to be surveilled with echocardiograms after insertion? · Secondary prevention guidelines o Are oestrogens CI in ESUS patients? o What is the stroke risk after PFO closure? o Do PFOs run in families (e.g.: does this have any implication for risk in family members?) o Do ESUS patients have the same stroke rehabilitation requirements as other stroke patients?
1 Educational activity hour
Date: 01/01/2026 Location: Other
This activity aims to outline the seriousness of AF-associated stroke and recurrent stroke, with a particular emphasis on understanding which patients cannot safely take oral anticoagulation therapy and which patients continue to stroke despite treatment. It aims to raise awareness amongst GPs of the option for left atrial appendage closure in such patients as a stroke risk mitigation therapy in appropriately selected patients and assist GPs in identifying which patients would benefit from a discussion with a multidisciplinary team regarding LAA closure.
1 Educational activity hour
Date: 01/01/2026 Location: Other
This online headache masterclass seeks to guide the participants through the complexities of headache and migraine presentations using a case-based format.
1 Educational activity hour
Date: 01/01/2026 Location: Other
This online headache masterclass seeks to guide the participants through the complexities of headache and migraine presentations using a case-based format.
1.5 Educational activity hours
Date: 01/01/2026 Location: Other
This online headache masterclass seeks to guide the participants through the complexities of headache and migraine presentations using a case-based format.
1.5 Educational activity hours
Date: 01/01/2026 Location: Other
This online headache masterclass seeks to guide the participants through the complexities of headache and migraine presentations using a case-based format.
1.5 Educational activity hours
Date: 01/01/2026 Location: Other
Around 80% of women in Australia will experience symptoms of menopause. 50% of women in their 50’s get significant symptoms; 20% get moderate or severe hot flushes or night sweats. Only 15-20% of women are on effective treatment for their symptoms.The overwhelming majority of Australian women experiencing menopausal symptoms will be managed exclusively by their GP. Despite the findings of the Women’s Health Initiative of 2002 now being largely rebuffed for its design imperfections, the negative views of menopausal hormonal therapy (MHT) and overstated risks of adverse effects endure in many health practitioners. Without the proactive and clinically up-to-date treatment via general practitioners, many Australian women face the prospect of a peri-menopause experience with inadequate access to appropriate therapies.Moreover, while mood symptoms are listed on the Menopause Symptoms Checklist, there is poor recognition and acceptance of the emerging evidence that the menopause can cause depressive illness in its own right, including in women who have never before had a mood disorder. A paradigm shift in thinking about mood symptoms in peri-menopausal women is needed- to understand the cognitive and emotional effects of oestrogen deficiency and to offer women appropriate and targeted therapies.
1 Educational activity hour
Date: 01/01/2026 Location: Other
Lipoedema is a disease of the loose connective tissues leading to dysregulated and abnormal growth of mainly fatty tissue. This results in disfiguring and painful adipose tissue that appears disproportionate to the size and shape of the affected person’s body. It affects 11% of people worldwide and is very commonly misdiagnosed as lipoedema or obesity. Lack of awareness of this condition by the medical profession and an insistence that the adiposity is obesity causes significant distress in patients, particularly because this adiposity is not amenable to usual weight reduction measures. An urgent need for increased awareness and understanding among clinicians exists so that patients can be correctly diagnosed and evidence-based treatments options offered, and so that harmful narratives about this phenotype can be eliminated.
1.5 Educational activity hours
Date: 01/01/2026 Location: Other
Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that affects men as they age. It is the most common urological condition in men over 50, with up to 80% of men experiencing symptoms by the age of 80. In Australia, around 1 in 5 men aged 50 and over have been diagnosed with BPH. The most common symptoms of BPH are difficulty urinating, a weak urine stream, and frequent urination, especially at night. There is no cure for BPH, but there are treatments available to help manage the symptoms. Minimally invasive techniques are used to treat BPH when medications are not effective or when the patient prefers a less invasive option, yet awareness of these options in low in general practitioners.The education provides the GP with the required knowledge concerning when to consider minimally invasive treatment options, what these options are and how to access them. By increasing GP awareness of these treatment options, patients with BPH will have greater choice in how they wish to manage their condition.
1 Educational activity hour